Frontiers in Bioengineering and Biotechnology (Jul 2023)

Nanomedical research and development in Spain: improving the treatment of diseases from the nanoscale

  • Paula Fernández-Gómez,
  • Carmen Pérez de la Lastra Aranda,
  • Carmen Pérez de la Lastra Aranda,
  • Carlota Tosat-Bitrián,
  • Carlota Tosat-Bitrián,
  • Jesús Alejandro Bueso de Barrio,
  • Sebastián Thompson,
  • Begoña Sot,
  • Begoña Sot,
  • Begoña Sot,
  • Gorka Salas,
  • Gorka Salas,
  • Álvaro Somoza,
  • Álvaro Somoza,
  • Ana Espinosa,
  • Ana Espinosa,
  • Milagros Castellanos,
  • Valle Palomo,
  • Valle Palomo,
  • Valle Palomo

DOI
https://doi.org/10.3389/fbioe.2023.1191327
Journal volume & issue
Vol. 11

Abstract

Read online

The new and unique possibilities that nanomaterials offer have greatly impacted biomedicine, from the treatment and diagnosis of diseases, to the specific and optimized delivery of therapeutic agents. Technological advances in the synthesis, characterization, standardization, and therapeutic performance of nanoparticles have enabled the approval of several nanomedicines and novel applications. Discoveries continue to rise exponentially in all disease areas, from cancer to neurodegenerative diseases. In Spain, there is a substantial net of researchers involved in the development of nanodiagnostics and nanomedicines. In this review, we summarize the state of the art of nanotechnology, focusing on nanoparticles, for the treatment of diseases in Spain (2017–2022), and give a perspective on the future trends and direction that nanomedicine research is taking.

Keywords